About the Centre of molecular inflammation research (CEMIR)

About the Centre of molecular inflammation research (CEMIR)


CEMIR research group, March 2, 2016. Photo: Jacob S. Jensen

About Cemir

The vision of the Centre of Molecular Inflammation Research (CEMIR) is to lay the foundation for identifying new therapeutic targets and developing new diagnostic tools for inflammatory diseases.

This will happen through an integrated 10-year programme of research and research training in molecular innate immune responses. CEMIR was established on 10. June 2013 as a Centre of Excellence (SFF) appointed by the Research Council of Norway.


Inflammation is a host response that is triggered by infection and tissue injury. A controlled inflammatory response is needed to fight infections and to heal wounds, but it can become detrimental if it is dysregulated as seen in chronic inflammatory disorders like cardiovascular disease, diabetes, Alzheimer's disease, inflammatory bowel disease, obesity, cancer, and others.

Drawing on major recent advances in the field of innate immunity and cell biology, CEMIR's research programme will detail the molecular and cell biological principles for initiation and regulation of inflammatory responses through the use of basic research, in vitro- and in vivo models and unique biobanks. The localisation of CEMIR in an integrated University hospital environment will facilitate translational research on human disease.

Host institution

Centre of Molecular Inflammation Research (CEMIR) is hosted by the Faculty of Medicine and Health Sciences (MH) at the Norwegian University of Science and Technology (NTNU).

The CEMIR activities are located in Kunnskapssenteret at Campus Øya and St. Olavs hospital. CEMIR is a centre at the Department of Cancer Research and Molecular Medicine, NTNU.



  • Pål Romundstad, Vice-dean, Faculty of Medicine and Health Sciences, NTNU
  • Torstein Baade Rø, Head of Department of Clinical and Molecular Medicine, NTNU
  • Lars Gunnar Landrø, Department of Biomedical Laboratory Science, NTNU
  • Gilda Susan Opland, Head of clinic, Laboratoriemedisinsk klinikk, St. Olavs hospital


Scientific Advisory Board (SAB)



CEMIR works in close cooperation with St. Olavs hospital and Central Norway Regional Health Authority, Helse Midt-Norge

Annual report 2018

CEMIR Annual Report 2014

CEMIR Annual Report 2017


CEMIR Annual Report 2016

Annual Report 2015